Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-09-30
Fuller Julie Files Zoetis Inc. Class A Common Stock (ZTS) Form 4 - September 30, 2026
Fuller Julie traded 1.1K ZTS shares worth $19.1K in this Form 4 filing, reported to the SEC on 2026-09-30.
- Insider
- Fuller Julie
- Issuer
- Zoetis Inc. Class A Common Stock ZTS · NYSE
- Filed
- Period
- 2026-09-30
- Accession
- 0001628280-26-064578
- Source
- Official filing on sec.gov ↗
Transactions (3)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Fuller Julie | 2026-09-30 | Buy | 799 | - | $0.00 | Direct |
| Fuller Julie | 2026-09-30 | Sell | 274 | $69.83 | $19.1K | Direct |
| Net change | +525 | −$19.1K | ||||
About Zoetis Inc. Class A Common Stock
Zoetis Inc. Class A Common Stock represents Zoetis, a global animal health company focused on medicines, vaccines, diagnostics, and related technologies for pets and livestock. Zoetis develops and markets products used by veterinarians, livestock producers, and pet owners across companion animals such as dogs, cats, and horses, as well as livestock including cattle, swine, poultry, fish, and sheep. Its portfolio includes parasiticides, dermatology treatments, pain and sedation products, anti-infectives, diagnostic tools, genetic tests, and precision animal health solutions. The company also provides reference laboratory services, rapid tests, instruments, and other non-pharmaceutical offerings that support disease detection and animal care. Headquartered in Parsippany, New Jersey, Zoetis operates in the United States and international markets, serving a broad range of animal health needs across clinical, agricultural, and diagnostic settings.
Track ZTS insider activity
Get alerted when Zoetis Inc. Class A Common Stock executives buy or sell their shares.